SiNtx Technologies Inc (SINT)

[boston745]

Its interesting, but Hofmann and Link's connections to Zimmer are mentioned in the 2007 IPO yet that information was withheld in the 2013 IPO paperwork in regards to Dr. Bal being a principal investigator for Zimmer from 2002 and the information that Zimmer acquired Centerpulse in 2003 included in Dr Link's 2007 blurb.

2007 IPO S-1 attempt

Max Link, Ph.D. has served as the Chairman of our board of directors since October 2003. Dr. Link served as Chairman of the Board and Chief Executive Officer of Centerpulse AG, the largest orthopedics company in Europe, from March 2002 until October 2003, when Centerpulse was acquired by Zimmer Holdings, Inc. Prior to joining Centerpulse, Dr. Link served as the Chief Executive Officer at Corange Limited/Boehringer Mannheim and as Chairman and Chief Executive Officer at Sandoz Pharmaceuticals (now part of Novartis). Since 1994, Dr. Link has been actively involved as a director in development stage companies in the healthcare and biopharmaceutical field both in the United States and in Europe, including Human Genome Sciences, Inc., Alexion Pharmaceuticals, Inc., Celsion Corporation and Discovery Laboratories, Inc. Dr. Link received his Ph.D. in economics from the University of St. Gallen, Switzerland in 1970.

2013 IPO S-1

Max E. Link, Ph.D. has served as the chairman of our board of directors since October 2003. Dr. Link was chairman of the board of directors and Chief Executive Officer of Centerpulse AG, a medical implant company from March 2002 to October 2003. Prior to joining Centerpulse, Dr. Link was Chief Executive Officer of Corange (Bermuda), the parent company of Boehringer Mannheim Corporation and chairman of the board of directors and chief executive officer of Sandoz Pharma, Ltd., now part of Novartis Corporation, a manufacturer of pharmaceutical products. Dr. Link is chairman of the boards of directors of three publicly listed biopharmaceutical companies, Alexion Pharmaceuticals, Inc., Celsion Corporation and CytRx Corporation. Dr. Link holds a Ph.D. in Economics from University of St. Gallen (Switzerland).

As you can see, no mention of Zimmer in the 2013 IPO paperwork. Its like someone wanted this information withheld...hmm.
Zimmer is mentioned 13 times in the 2007 IPO and is only mentioned 3 times in the 2013 IPO but only as examples of competition or recalls.

Dr Hofmann 2007 IPO paperwork:

Aaron A. Hofmann, M.D. is our co-founder and has been a member of our board of directors since 1996. Dr. Hofmann is a nationally and internationally recognized orthopedic surgeon, known for his accomplishments in developing total hip and knee replacement systems, innovative surgical approaches in hip and knee surgery and basic research on human bone dynamics. Dr. Hofmann holds 14 patents, many of which are directed at inventions involving hip and knee implants. Since 2003, Dr. Hofmann has been a design surgeon for Zimmer Holdings, Inc., the largest orthopedics company in the world. Dr. Hofmann, working with a team of orthopedic surgeons, helped design Zimmer’s new gender knee specifically designed for women. Since 1992, Dr. Hofmann has been a Professor of Orthopedic Surgery at the University of Utah School of Medicine and Chief of Orthopedics for the Veteran Affairs Medical Center in Salt Lake City, Utah since 1988. He earned his M.D. at the Southwestern Medical School in Dallas, Texas, was a resident at Parkland Memorial Hospital in Dallas, Texas, and a Joint Reconstruction Fellow at the Montreal General Hospital. Dr. Hofmann is a diplomate of the American Board of Orthopaedic Surgery and an active member of the American Orthopaedic Association, the American Academy of Orthopaedic Surgeons, the Orthopaedic Research Society, the Society for Arthritic Joint Surgery and the Knee Society.

Dr Bal 2013 IPO paperwork:

B. Sonny Bal, M.D. has served on our board of directors since February 2012. Dr. Bal is Professor & Chief of Adult Reconstruction at the University of Missouri, Columbia, specializing in hip and knee replacement surgery. He also is an Adjunct Professor of Material Sciences at the University of Missouri at Rolla. Dr. Bal is a member of the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons. Dr. Bal received his M.D. degree from Cornell University and an M.B.A. from Northwestern University, and a J.D. from the University of Missouri. Dr. Bal is a licensed attorney and co-founder of the Bal Brenner law firm in North Carolina.

We believe that Dr. Bal’s expertise in orthopedic surgery and his specialty in hip and knee replacement surgery qualifies him to serve on our board of directors.

As you can see, no mention of Dr. Bals work as a principle investigator for Zimmer. However the information disclosed about Dr Bal in the 2007 IPO paperwork also does not contain that information. Less important im sure as he was only a surgeon consultant at the time.

https://www.sec.gov/Archives/edgar/data/1269026/000119312513435409/d593074ds1.htm pg 89/90